LaurenceCooperMD
Pediatric Hematology & Oncology • Houston, TXProfessor of Pediatrics, University Tex Houston
Dr. Cooper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-563-5393
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 1996 - 1999- University of WashingtonResidency, Pediatrics, 1994 - 1996
Case Western Reserve University School of MedicineClass of 1994
Certifications & Licensure
CA State Medical License 2001 - Present
UT State Medical License 2017 - 2026
TX State Medical License 2006 - 2016
WA State Medical License 1999 - 2002- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2012-2013
- Join now to see all
Clinical Trials
- Long-Term Follow-Up of Recipient of Gene Transfer Research Start of enrollment: 2011 Dec 09
Publications & Presentations
PubMed
- 208 citationsIdentification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T CellsMatthew J. Frigault, Jihyun Lee, Maria C. Basil, Carmine Carpenito, Shinichiro Motohashi
Cancer Immunology Research. 2015-01-19 - 166 citationsRegulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial.E. Antonio Chiocca, John S. Yu, Rimas V. Lukas, Isaac H. Solomon, Keith L. Ligon
Science Translational Medicine. 2019-08-14 - 78 citationsGrowth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell TherapyYin Liu, Hong-Wei Wu, Michael A. Sheard, Richard Sposto, Srinivas S. Somanchi
Clinical Cancer Research. 2013-04-15
Journal Articles
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast CancerAustin D Williams, Amy S Clark, Paul J Zhang, Julia Tchou, Bruce L Levine, Jennifer M Matro, Laurence J Cooper, Alycia So, Lynn M Schuchter, Carl H June, Angela M DeMi..., Clinical Cancer Research
Press Mentions
- Brain Cancer Biotech Ziopharm Snaps up New CEO from Kuur TherapeuticsAugust 30th, 2021
- Aldevron Announces Virtual Breakthrough Speaker Series: Dr. Laurence Cooper Is Inaugural GuestApril 29th, 2021
Ziopharm Oncology Announces Election of Robert Postma to Its Board of DirectorsFebruary 5th, 2021- Join now to see all
Grant Support
- Ucb-Derived Cd19-Specific T Cells For Universal Treatment Of B-Cell MalignancyNational Cancer Institute2010–2011
- T-Cell Therapy For B-Lineage Acute Lymphoblastic LeukemiaNational Cancer Institute2010–2011
- Enhancing The Efficacy Of Cd19-Specific Cord Blood-Derived T CellsNational Cancer Institute2007–2011
- Adoptive Immunotherapy After Umbilical Cord Blood TransplantNational Cancer Institute2007–2011
- Ncounter PREP Station And The Digital AnalyzerNational Center For Research Resources2010
- Targeting Post-Transplant Minimal Residual CD19+ All With Genetically-National Cancer Institute2006–2010
- Ucb-Derived Cd19-Specific T Cells For Universal Treatment Of B-Cell MalignancyNational Cancer Institute2007–2008
- Imaging Infused CD19 Specific T Cells In The TumorNational Cancer Institute2007–2008
- Cd19-Specific T-Cell Therapy For Follicular LymphomaNational Cancer Institute2003–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
